Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, today announced the presentation of nearly 75 company-affiliated research ...

MEGAROBO, a leading provider of advanced productivity tools for life sciences, has recently unveiled the CellVuetm T2000 high-content cell imaging system. The new cell imaging system is more than a ...

Breakthroughs in genomic research have revolutionized the systematic examination of cellular systems, enabling us to ...

TelePIX, a total satellite solution company, announced the successful completion of the in-space demonstration of TetraPLEX, an artificial intelligence (AI) processor for satellites launched in August ...

Abbott Laboratories, Inc. ABT has announced a new, first-of-its-kind clinical trial designed to improve outcomes in patients with worsening heart failure who could benefit from advanced therapy ...

Sage Therapeutics, Inc. SAGE reported a loss of $1.53 per share for the third quarter of 2024, wider than the Zacks Consensus ...

Vaxxas, has announced the company has been granted a licence to develop a next-generation vaccine antigen (DS2).

Real progress in health inequities requires meeting communities where they are and addressing the root causes of medical ...

Supported by funds from the National Research University Fund (NRUF), the new center is in UTA’s Science and Engineering Innovation and Research (SEIR) building on W. Mitchell Street. SEIR opened in ...

Researchers have identified a crucial biochemical mechanism that could allow Huntington’s disease to be studied before symptoms appear, offering hope for early intervention.

A picture may be worth a thousand words, but they both have a lot of work to do to catch up to BiomedGPT. A Lehigh University ...